SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • November 2nd, 2021 • Sage Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Severance and Change in Control Agreement (this “Agreement”) is made as of September 13, 2021 by and between Sage Therapeutics, Inc., a Delaware corporation (the “Company”), and Christopher Benecchi (the “Executive”) and shall become effective on the date of hire with the Company.
AMENDMENT NO. 1 TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 2nd, 2021 • Sage Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 1 (“Amendment No. 1”) is made as of July 13, 2021 (“Amendment No. 1 Effective Date”) by and between Sage Therapeutics, Inc. (“Licensee”) and Washington University (“WU”).
